Cargando…
Protective Effects of Pioglitazone on Cognitive Impairment and the Underlying Mechanisms: A Review of Literature
Pioglitazone, a peroxisome proliferator-activated receptor gamma (PPARγ) agonist, is known to have anti-inflammatory and anti-oxidant effects on the brain, and its clinical potential in the treatment of cognitive impairment in diseases such as Alzheimer's disease (AD) and Parkinson disease (PD)...
Autores principales: | Alhowail, Ahmad, Alsikhan, Rawan, Alsaud, May, Aldubayan, Maha, Rabbani, Syed Imam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441149/ https://www.ncbi.nlm.nih.gov/pubmed/36068789 http://dx.doi.org/10.2147/DDDT.S367229 |
Ejemplares similares
-
The Ameliorative Effect of Pioglitazone against Neuroinflammation Caused by Doxorubicin in Rats
por: Alsaud, May M., et al.
Publicado: (2023) -
Protective Effect of Galantamine against Doxorubicin-Induced Neurotoxicity
por: Alsikhan, Rawan S., et al.
Publicado: (2023) -
Mechanisms Underlying Cognitive Impairment Induced by Prenatal Alcohol Exposure
por: Alhowail, Ahmad
Publicado: (2022) -
The Impact of Metformin on the Development of Hypothyroidism and Cardiotoxicity Induced by Cyclophosphamide, Methotrexate, and Fluorouracil in Rats
por: Alhowail, Ahmad H., et al.
Publicado: (2023) -
Influence of pioglitazone on experimental heart failure and hyperlipidemia in rats
por: Biswas, Arghya, et al.
Publicado: (2012)